Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 36 (1-3), 16-25

Role of PACAP in Ischemic Neural Death

Affiliations
Review

Role of PACAP in Ischemic Neural Death

Hirokazu Ohtaki et al. J Mol Neurosci.

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide that was first isolated from an ovine hypothalamus in 1989. Since its discovery, more than 2,000 papers have reported on the tissue and cellular distribution and functional significance of PACAP. A number of papers have reported that PACAP but not the vasoactive intestinal peptide suppressed neuronal cell death or decreased infarct volume after global and focal ischemia in rodents, even if PACAP was administered several hours after ischemia induction. In addition, recent studies using PACAP gene-deficient mice demonstrated that endogenous PACAP also contributes greatly to neuroprotection similarly to exogenously administered PACAP. The studies suggest that neuroprotection by PACAP might extend the therapeutic time window for treatment of ischemia-related conditions, such as stroke. This review summarizes the effects of PACAP on ischemic neuronal cell death, and the mechanism clarified in vivo ischemic studies. In addition, the prospective mechanism of PACAP on ischemic neuroprotection from in vitro neuronal and neuronal-like cell cultures with injured stress model is reviewed. Finally, the development of PACAP and/or receptor agonists for human therapy is discussed.

Similar articles

See all similar articles

Cited by 48 PubMed Central articles

See all "Cited by" articles

References

    1. Am J Physiol. 1992 Dec;263(6 Pt 2):H1659-69 - PubMed
    1. Peptides. 2006 Jul;27(7):1871-6 - PubMed
    1. Ann N Y Acad Sci. 2006 Jul;1070:507-11 - PubMed
    1. Novartis Found Symp. 2006;276:181-9; discussion 189-92, 233-7, 275-81 - PubMed
    1. Curr Top Med Chem. 2006;6(2):151-63 - PubMed

Publication types

Substances

LinkOut - more resources

Feedback